Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. EFFECT Other Notice of Effectiveness
  2. 424B4 Offering Prospectus
  3. POS EX Other Post-effective Amendment
  4. S-1MEF Other S-1MEF
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. S-1 Offering Registration Statement
  8. 424B3 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. SC 13G/A Stake Amended Statement of Ownership
  11. UPLOAD Other SEC-generated Letter
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1/A Offering Registration Statement
  14. S-1/A Offering Registration Statement
  15. DRS Other Draft Registration Statement
  16. 8-K Event Regulation FD disclosure · Other events
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 27 of 33 · 653 filings